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Purpose: To investigate the effects of laser photocoagulation (LP)-induced ocular hypertension (OHT) on the survival
and retrograde axonal transport of retinal ganglion cells (RGC), as well as on the function of retinal layers.
Methods: Adult albino Swiss mice (35–45 g) received laser photocoagulation of limbal and episcleral veins in the left
eye. Mice were sacrificed at 8, 17, 35, and 63 days. Intraocular pressure (IOP) in both eyes was measured with a Tono-
Lab before LP and at various days after LP. Flash electroretinogram (ERG) scotopic threshold response (STR) and a- and
b-wave  amplitudes  were  recorded  before  LP  and  at  various  times  after  LP.  RGCs  were  labeled  with  10%
hydroxystilbamidine methanesulfonate (OHSt) applied to both superior colliculi before sacrifice and in some mice, with
dextran tetramethylrhodamine (DTMR) applied to the ocular stump of the intraorbitally transected optic nerve. Retinas
were immunostained for RT97 or Brn3a. Retinas were prepared as whole-mounts and photographed under a fluorescence
microscope. Labeled RGCs were counted using image analysis software, and an isodensity contour plot was generated
for each retina.
Results: IOP increased to twice its basal values by 24 h and was maintained until day 5, after which IOP gradually declined
to reach basal values by 1 wk. Similar IOP increases were observed in all groups. The mean total number of OHSt+ RGCs
was 13,428±6,295 (n=12), 10,456±14,301 (n=13), 12,622±14,174 (n=21), and 10,451±13,949 (n=13) for groups I, II, III,
and IV, respectively; these values represented 28%, 23%, 26%, and 22% of the values found in their contralateral fellow
retinas. The mean total population of Brn3a+ RGCs was 24,343±5,739 (n=12) and 10,219±8,887 (n=9), respectively, for
groups I and III; these values represented 49% and 20%, respectively, of the values found in their fellow eyes. OHT retinas
showed an absence of OHSt+ and DTMR+ RGCs in both focal wedge-shaped and diffuse regions of the retina. By 1 wk,
there was a discrepancy between the total number of surviving OHSt+ RGCs and Brn3a+ RGCs, suggesting that a large
proportion of RGCs had impaired retrograde axonal transport. In the retinal areas lacking backlabeled RGCs, neurofibrillar
staining revealed aberrant expression of RT97 within axons and RGC bodies characteristic of axotomy. Elevated IOP
induced significant reductions in the registered ERG waves, including positive STR, a- and b-waves, that were observed
by 24 h and remained throughout the period of study for the three groups analyzed.
Conclusions: LP of the perilimbal and episcleral veins resulted in OHT leading to a lack of retrograde axonal transport
in approximately 75% of the original RGC population. This lack did not progress further between 8 and 63 days, and it
was both focal (in sectors with the apex located in the optic disc) and diffuse within the retina. In addition, severe amplitude
diminutions of the STR and a- and b-waves of the ERG appeared as early as 24 h after lasering and did not recover
throughout the period of study, indicating that increased IOP results in severe damage to the innermost, inner nuclear, and
outer nuclear layers of the retina.
The  mammalian  retina  is  a  layered  structure  [1]  that
processes and sends to the brain the information obtained from
light  stimulation  in  the  visual  field.  This  is  done  with
increasing complexity in each of the three main neuronal
layers: the outer nuclear layer, where the cell bodies of the rod
and cone photoreceptors lie; the intermediate or inner nuclear
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layer,  where  the  cell  bodies  of  the  bipolar,  horizontal,
interplexiform,  and  amacrine  interneurons  reside;  and  the
innermost retinal layer, also known as the retinal ganglion cell
layer,  where  displaced  amacrine  interneurons  and  retinal
ganglion cells (RGCs), the sole output neurons of the retina,
reside [2]. A common disease that affects many of these retinal
neurons is glaucoma. Glaucomatous optic neuropathy is a
human  disease  that  characteristically  affects  the  RGC
population  but  may  also  affect  other  retinal  neuronal
populations [3], including the inner [4] and outer nuclear
layers of the retina [5,6]; it provokes optic disc changes and
Molecular Vision 2009; 15:2578-2598 <http://www.molvis.org/molvis/v15/a276>
Received 7 August 2009 | Accepted 3 November 2009 | Published 5 December 2009
© 2009 Molecular Vision
2578leads to visual field losses that may progress to complete
blindness. Effects on non-RGC neuronal populations in the
retina have been shown in several studies that investigated the
thickness and functional status of the inner and outer retinal
layers  both  morphologically  and  with  electroretinogram
(ERG) recordings [7,8]. Indeed, major wave components of
the ERG have been shown to be severely affected in humans
with glaucoma [9,10] or ocular hypertension (OHT) [11] as
well as in experimental glaucoma [12]. Experimental models
of elevated intraocular pressure (IOP) [13-17] have shown
important alterations of several ERG components, including
scotopic threshold response (STR),  a-wave, and  b-wave,
which are associated with RGCs, photoreceptors, and bipolar
cells, respectively.
Even though not all glaucoma visual field loss may be
correlated  with  IOP  [18]  and  lowering  IOP  does  not
completely halt progression of the disease [19], elevation of
IOP remains one of the most important risk factors associated
with the progression of glaucomatous optic neuropathy in
humans [20-22]. Up-to-date therapeutic intervention against
glaucoma progression is based mainly on medical or surgical
treatments to diminish IOP in an attempt to control or slow
the progression of the disease and its damaging effects [23,
24]. Thus, it is of interest to characterize the effects of elevated
IOP on retinal neurons.
In the present work, we have used one of the available
experimental models of OHT-induced retinal damage [24,
25] to study the mechanisms by which elevated IOP causes
retinal damage in adult albino mice. The experimental model
we have chosen is based on laser photocoagulation (LP) of the
perilimbal  and  episcleral  veins  [26],  a  method  originally
described to induce OHT in monkeys [27] and later modified
for albino rats [26,28-31] and pigmented mice [32,33]. These
models do not fully resemble human glaucoma, but they are
suitable to improve understanding of the pathophysiology
involved in OHT-induced retinal damage [25], as well as to
test  neuroprotective  strategies  and  substances  [25,34,35].
Injured RGCs are known to undergo early functional deficits
[17,36-38],  including  alterations  in  their  axoplasmic  flow
properties [26,39-43], in several metabolic functions such as
diminutions  of  their  Thy-1  mRNA  levels  [36,44-46],  or
induction of phagocytic activity in microglia [47,48], and in
the  regulation  of  a  substantial  number  of  genes  [49,50]
including the downregulation of Brn3a [51] shortly before cell
death. Transgenic mice are used in increasing numbers as
experimental models for various neurodegenerative diseases
[25], including the line of DBA/2 mice used as glaucomatous
optic  neuropathy  models  [3,52-57];  this,  with  their
availability,  their  well  characterized  genome,  and  the
relatively low cost of producing diverse genetic manipulations
[58], underscores the need to characterize the effects of ocular
hypertension in wild mice, as well. This has been done for
pigmented mice [17,32,59-61]. However, there is as yet no
information regarding the results of IOP in adult albino mice.
Thus, we have here extended our previous observations in the
adult albino rat [26] and further characterized the effects of
increased  IOP  in  the  retinal  neuronal  population  of  adult
albino mice. Specifically, we have investigated the fate of the
RGC population using various neuronal tracers and molecular
markers and studied the functional effects in the retinal layers
by recording full-field ERGs.
Our studies show, for the first time in adult albino Swiss
mice, that lasering of the limbal tissues results in elevated IOP,
which in turn induces several sequential degenerative events
in the RGC layer that result in degeneration of the RGC
population, with a time lapse between the first alteration in the
axoplasmic  flow  and  the  delayed  degeneration  of  the
intraocular axons and their parent cell bodies; this underlines
the opportunity for neuroprotective strategies to be applied
within  a  long  interval  before  actual  RGC  death  and  is
consistent with our recent studies in adult albino rats [26].
Moreover, we show permanent significant diminution of the
scotopic threshold response that is associated with the loss of
the  great  majority  of  RGCs  following  elevated  IOP;  this
indicates  the  value  of  noninvasive  functional  ERG
measurements  to  document  RGC  loss  in  adult  rodents.
Finally, we show permanent significant diminution of the
major components of the ERG, the  a-wave, and  the  b-wave,
all of which imply severe alterations of the inner and outer
nuclear layers of the retina. Short accounts of this work have
been published in abstract form [62,63].
METHODS
Animals and anesthetics: Experiments were performed on
adult male albino Swiss mice (35–45 g), obtained from the
breeding colony of the University of Murcia (Murcia, Spain).
Mice were housed in temperature- and light-controlled rooms
with a 12 h:12 h light-dark cycle and had food and water ad
libitum. Light intensity within the cages ranged from 9 to
24 lx. Animal care guidelines comparable those published by
the Institute for Laboratory Animal Research (Guide for the
Care and Use of Laboratory Animals) and the USA Public
Health Service (Public Health Service Policy on Humane Care
and Use of Laboratory Animals) were followed. In addition,
animal  manipulations  followed  institutional  guidelines,
European Union regulations for the use of animals in research,
and the ARVO statement for the use of animals in ophthalmic
and vision research.
All surgical manipulations were performed under general
anesthesia  induced  with  an  intraperitoneal  injection  of  a
mixture  of  ketamine  (75  mg/kg,  Ketolar®,  Parke-Davies,
S.L., Barcelona, Spain) and xylazine (10 mg/kg, Rompún®,
Bayer,  S.A.,  Barcelona,  Spain).  During  recovery  from
anesthesia, rats were placed in their cages, and an ointment
containing  tobramycin  (Tobrex®;  Alcon  Cusí  S.A.,
Barcelona,  Spain)  was  applied  on  the  cornea  to  prevent
corneal  desiccation.  Additional  measures  were  taken  to
minimize discomfort and pain after surgery. Animals were
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2579sacrificed with an intraperitoneal injection of an overdose of
pentobarbital  (Dolethal  Vetoquinol®,  Especialidades
Veterinarias, S.A., Alcobendas, Madrid, Spain).
Induction  of  ocular  hypertension:  To  induce  ocular
hypertension, the left eyes of anesthetized mice were treated
during a single session with a series of diode laser (532 nm,
Quantel Medical, Clermont-Ferrand, France) burns. The laser
beam was delivered directly, without any lenses, aimed at the
limbal and episcleral veins. The spot size, duration, and power
were 50–100 µm, 0.5 s, and 0.3 W, respectively. Four groups
of 12 (group I), 13 (group II), 21 (group III), and 13 (group
IV) mice were prepared, each receiving approximately 72
spots in a single session.
Measurement of intraocular pressure, experimental groups,
and survival intervals: To assess IOP in the treated mice, we
obtained accurate and reliable readings using the rebound
tonometer (Tono-Lab®; Tiolat, OY, Helsinki, Finland) [64,
65]. Both eyes of each animal were measured under anesthesia
before laser treatment and 1, 2, 3, 4, 5, 6, 7, 8, 14, 21, 28, 42,
or 56 days after treatment. At each time point, 36 consecutive
readings were performed for each eye, and the results were
averaged. To avoid fluctuations due to the circadian rhythm
of the mice [33] or to the elevated IOP itself [66], we tested
IOP  always  around  the  same  time,  preferentially  in  the
morning and immediately after deep anesthesia. Moroever,
because general anesthesia lowers IOP in rats, we measured
both the IOP-treated eye and the contralateral intact fellow
eye in all cases. Mice were divided into four groups that were
sacrificed and analyzed 8 (group I, n=12); 17 (group II, n=13),
35  (group  III,  n=21),  or  63  (group  IV,  n=13)  days  after
lasering.
Electroretinography recordings: One of the purposes of this
study was to evaluate the effects of OHT on the function of
the retina. To this end, we analyzed animals from groups II–
IV that were sacrificed at 17, 35, and 63 days, respectively.
Animals were dark-adapted for 8 h before ERG recordings,
and they were manipulated under dim red light (λ>600 nm).
Mice were anesthetized, their IOP was measured as above,
and bilateral pupil mydriasis was induced by applying in both
eyes a topical drop of 1% tropicamide (Colircusi tropicamida
1%®; Alcon-Cusí, S.A., El Masnou, Barcelona, Spain). The
light-stimulation device consisted of a Ganzfeld dome, which
ensures homogeneous illumination throughout the retina, with
multiple reflections of the light generated by light-emitting
diodes (LEDs), providing a wide range of light intensities. For
high-intensity  illuminations,  a  single  LED  placed  close
(1  mm)  to  the  eye  was  used.  The  recording  system  was
composed of Burian-Allen bipolar electrodes (Hansen Labs,
Coralville, IA) with a corneal contact shape; a drop of 2%
methylcellulose  (Methocel  2%®;  Novartis  Laboratories
CIBA Vision, Annonay, France) was placed between the eye
and the electrode to maximize conductivity of the generated
response. The reference electrode was placed in the mouth and
the ground electrode in the tail. Electrical signals generated in
the retina were amplified (x1000) and filtered (band pass from
1 Hz to 1000 Hz) using a commercial amplifier (Digitimer
Ltd., Letchworth Garden City, UK). The recorded signals
were  digitized  (Power  Lab;  ADInstruments  Pty.  Ltd.,
Chalgrove, UK) and displayed on a PC computer. Bilateral
ERG recording was performed simultaneously on both eyes.
Light stimuli were calibrated before each experiment, and the
calibration protocol ensured the same recording parameters
for both eyes. Scotopic ERG responses were recorded by
stimulating the retina with light intensities between 10−6 and
10−4  cd·s·m−2  for  the  scotopic  threshold  response  (STR),
between  10−4  and  10−2  cd·s·m−2  for  the  rod  response,  and
between 10−2 and 102 cd·s·m−2 for the mixed (rod and cone)
response. After five minutes of light adaptation (50 cd·m−2
background light), the photopic ERG responses were recorded
at a light intensity of 102 cd·s·m−2. For each light intensity, a
series  of  ERG  responses  was  averaged,  and  the  interval
between light flashes was adjusted to allow response recovery.
At the end of each session, the animals were treated with
topical tobramycin (Tobrex®; Alcon-Cusí, S.A., El Masnou,
Barcelona, Spain) in both eyes. The recordings were analyzed
using the normalization criteria established for the ISCEV for
the measures of amplitude and implicit time for the various
waves that were studied.
The STR was analyzed for each stimuli; positive scotopic
threshold response (pSTR) was measured from the baseline
to the “hill” of the positive deflection, ~110 ms from the flash
onset. The a-wave was measured from the baseline to the first
valley, ~10 ms from the flash onset. The b-wave amplitude
was measured from the bottom of the a-wave valley to the top
of the hill of the positive deflection; the time point of the
measurement varied depending on the light intensity used.
Implicit  time  was  measured  from  the  presentation  of  the
stimulus to the top of the b-wave. Data from laser-treated and
untreated eyes were compared; ERG wave amplitudes and
implicit times were calculated for each animal group, II–IV.
The  results  were  analyzed  with  SigmaStat®  3.1  for
Windows®  (Systat  Software  Inc.,  Richmond,  CA).
Descriptive statistics were calculated and t-test was used in all
studied groups for the comparison between percent response
both pre- and post-lasering. We performed the same tests
before surgery to demonstrate similar functionality in both
eyes before the lesions. One-way ANOVA was applied for the
comparison between different animal groups, as an attempt to
estimate a possible interrelation between the progressions of
response along studied times. The statistic significance was
placed in a p<0.05 for all tests and the statistic was always of
two tails.
Retrograde  labeling  of  retinal  ganglion  cells  with
hydroxystilbamidine  methanesulfonate:  To  identify  RGCs
that  retain  their  axoplasmic  transport  after  lasering,
hydroxystilbamidine  methanesulfonate  (OHSt)  (Molecular
Probes,  Leiden,  The  Netherlands),  a  small  molecule
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2580(472.53  kDa  Mw)  with  similar  fluorescent  and  tracer
properties to Fluorogold® [67], was applied to both superior
colliculi (SCi) one week before animal sacrifice following
previously  described  methods  that  are  standard  in  our
laboratory [51,68]. In brief, after exposing the midbrain, a
small pledget of gelatin sponge (Espongostan Film, Ferrosan
A/S, Denmark) soaked in saline containing 10% OHSt in 0.9%
NaCl and 10% dimethyl sulphoxide (DMSO) was applied
over the entire surface of both SCi [68-71]. Previous studies
in control mice indicate that OHSt application to both SCi,
which are the main retinorecipient target regions in the brain,
results in the labeling of 48,733 RGCs one week later; these
represent 98.5% of the RGC population in albino Swiss mice
[69].
Retrograde labeling of retinal ganglion cells with dextran
tetramethylrhodamine: To identify RGCs surviving retinal
lasering with a competent axon at the level of the optic nerve
(ON)  head,  the  fluorescence  tracer  dextran
tetramethylrhodamine  (DTMR;  3,000  MW;  Molecular
Probes, Inc. Eugene, OR) was applied to the ocular stump of
the intraorbitally transected left optic nerve 5 days after OHSt
application and 2 days before sacrifice in groups II, III, and
IV, following already described methods that are standard in
our Laboratory [26,43,69,72-74]. In brief, small crystals of
DMTR were applied to the ocular stump of the left ON, which
had been intraorbitally sectioned approximately 0.5 mm from
the eye. Care was taken not to damage the retinal vessels that
run in the inferior aspect of the dural sheaths [75,76]. DTMR
diffuses through the axon toward the cell soma at a rate of
2 mm/h without requiring active transport [77] producing an
intense labeling [28,69]. In these animals, DTMR would label
the surviving retinofugal RGC population with a competent
axon at the level of the ON head, whereas OHSt would identify
RGCs that retain their capability to transport the compound
from the SCi back to their cell somas in the retina.
Animal  processing:  Mice  were  deeply  anesthetized  and
perfused  transcardially  through  the  ascending  aorta  with
saline and 4% paraformaldehyde in 0.1 M phosphate buffer
(PB;  1:1.087  sodium  phosphate  monobasic  and  sodium
phosphate dibasic at pH 7.2–7.4). The orientation of each eye
was carefully maintained with a suture placed on the superior
pole immediately after deep anesthesia and before perfusion
fixation. Moreover, upon dissection of the eye, the insertion
of the rectus muscle and the nasal caruncle were used as
additional  landmarks.  Both  retinas  were  dissected  and
prepared as flattened whole-mounts by making four radial
cuts  (the  deepest  in  the  superior  pole);  post-fixed  for  an
additional hour; rinsed in 0.1 M PB; mounted vitreal side up
on  subbed  slides;  and  covered  with  antifading  mounting
media  containing  50%  glycerol  and  0.04%  p-
phenylenediamine in 0.1 M sodium carbonate buffer (pH 9).
Immunocytochemical studies: Twelve animals from group I
and nine animals from group III (sacrificed 8 and 35 days after
lasering,  respectively)  were  further  processed  for  Brn3a
immunocytochemistry in whole-mounts following previously
described methods [51]. Brn3a is part of the Brn3 family of
POU-domain transcription factors, recently shown to be a
reliable marker to quantify naïve and axotomized RGCs in
adult  albino  rats  [51].  Axotomized  RGCs  are  known  to
undergo downregulation of the Brn3a gene [49,50] shortly
before they die. Moreover, two to three days after optic nerve
injury, there is an important decrease in the expression of the
protein  (as  observed  by  western  blotting  and
immunohistofluorescence)  [51];  thus,  an  indirect  way  to
examine the physiologic functional properties of RGCs is to
examine their Brn3a expression. In brief, immediately after
retinal dissection, retinas were permeabilized in PBS 0.1 M
(pH 7.2–7.4) 0.5% Triton® X-100 by freezing them overnight
at  −70  °C,  rinsed  in  new  PBS  0.5%  Triton®X-100,  and
incubated the following day at 4 °C with goat anti-Brn3a
(C-20)  antibody  (Santa  Cruz  Biotechnologies  Heidelberg,
Germany) diluted 1:100 in blocking buffer (PBS, 2% BSA
(BAS), 2% Triton®X-100). Then, retinas were washed three
times in PBS and incubated 2 h at room temperature (RT) with
a secondary antibody, Alexa Fluor-568 donkey antigoat IgG
(H+L)  (Molecular  Probes,  Invitrogen,  Barcelona,  Spain),
diluted  1:500  in  blocking  buffer.  Finally,  retinas  were
thoroughly washed in PBS, mounted vitreal side up on subbed
slides, and covered with antifading mounting media.
The intraretinal course of RGC axons was examined in
retinal whole mounts with the monoclonal antibody RT97
(Hybridoma Bank, University of Iowa, Iowa City, IA) in both
retinas of animals from groups I–IV. The RT97 antibody
developed  by  John  Wood  [78]  was  obtained  from  the
Developmental Studies Hybridoma Bank developed under the
auspices of the NICHD and maintained by the University of
Iowa, Department of Biologic Sciences, Iowa City, IA. This
antibody  was  raised  in  mouse  against  Wistar  rat
neurofilaments  and  recognizes  in  western  blots  the
phosphorylated  heaviest  subunit  (200  kDa)  of  the
neurofilament triplet [78-80]. In our laboratory, we have used
this  commercial  antibody  extensively,  because,  in  our
experience,  RT97  labels  RGC  axons  intensely  and  the
horizontal cell plexus faintly in the rodent whole-mount retina
[74,81-86]. Moreover, it is a good marker for axotomized
RGCs and their axons [26,74,81-84]. Immunodetection was
performed using protocols that are standard in our laboratory
[26,71,74,82,83,85,86].  In  brief,  whole-mount  dissected
retinas  were  incubated  1  h  at  RT  in  blocking  buffer
(Triton®X-100  2%  and  2.5%  BSA  in  PBS)  followed  by
overnight incubation at 4 °C with the primary antibody diluted
1:1,000  in  the  same  blocking  buffer.  The  following  day,
retinas were washed in PBS (3×15 min at RT), and secondary
detection was performed by 2 h incubation at RT with goat
antimouse FITC antibody (F-4018; Sigma-Aldrich, St. Louis,
MO) diluted 1:50 in blocking buffer. After that, retinas were
washed in PBS, mounted vitreal side up on gelatin-coated
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glycerol and 0,04% p-phenylenediamine in 0.1 M sodium
carbonate buffer (pH 9).
We  performed  several  negative  controls  for
immunohistochemistry by incubating the retinas without the
primary antibodies, and we did not obtain specific signals.
Retinal analysis: Retinas were examined and photographed
under a fluorescence microscope (Axioscop 2 Plus; Zeiss
Mikroskopie, Jena, Germany) equipped with an ultraviolet
(BP 365/12, LP 397) filter that allows the observation of the
white-gold OHSt fluorescence, a rhodamine (BP 546/12, LP
590)  filter  that  allows  the  observation  of  the  orange-red
DTMR fluorescence of the Alexa Fluor-568 donkey antigoat
IgG (H+L) antibody, and a fluorescein (BP 450/490, LP 515–
565)  filter  that  allows  the  observation  of  the  fluorescein
conjugated antibodies. The microscope was also equipped
with  a  digital  high-resolution  camera  (ProgResTM  C10;
Jenoptik, Jena, Germany) and a computer-driven motorized
stage  (ProScanTM®  H128  Series;  Prior  Scientific
Instruments, Cambridge, UK), connected to an image analysis
computer program (Image-Pro Plus 5.1 for Windows (IPP);
Media Cybernetics, Silver Spring, MD) with a microscope
controller  module  (Scope-Pro  5.0  for  Windows;  Media
Cybernetics, Silver Spring, MD).
Retinal whole-mount reconstructions were obtained as
recently  described  in  detail  [68,69].  In  brief,  retinal
Figure 1. Measurements of intraocular pressure. A-D: Histograms
show mean (±SD) intraocular pressures (IOP) for the right eye (RE)
and left eye (LE) in groups I (A), II (B), III (C), and IV (D) of mice
sacrificed  8,  17,  35,  and  63  days,  respectively,  after  laser
photocoagulation of the limbal and episcleral veins of the LE. Each
received an average of 72 laser-burning spots in a single session. IOP
values in group I (A) rose and peaked by day 1 post-treatment, were
maintained  until  day  5,  and  then  gradually  returned  to  basal
preoperative levels by the end of a week. IOP values in groups II
(B),  III  (C),  and  IV  (D)  followed  a  similar  pattern  of  pressure
variations, indicating that elevated IOP was not maintained beyond
1 week.
multiframe acquisitions were photographed in a raster scan
pattern in which frames were captured side-by-side with no
gap or overlap between them with a 20X objective (Plan-
Neofluar,  20/0.50;  Zeiss  Mikroskopie,  Jena,  Germany).
Single frames were focused manually before the capture of
each  image,  which  was  then  fed  into  the  image  analysis
program. A scan area was defined to cover the whole retina,
consisting of a matrix of m frames in columns and n frames
in rows, where the total number of frames in the scan area is
indicated by frames in columns times frames in rows (m×n).
Usually,  140  images,  each  measuring  0.2161  mm2  at  a
resolution of 300 dots per inch, were taken for each mouse
retina. The images of each retina were saved in a folder as a
set of 24-bit color image pictures, and these images were later
combined automatically into a single tiled high-resolution
composite image of the whole retina using IPP. Reconstructed
images were further processed using image-editing software
(Adobe® Photoshop® CS ver. 8.0.1; Adobe Systems Inc., San
Jose, CA) when needed to produce printouts.
Retinal ganglion cell counts and isodensity maps: All images
taken from the retinas were processed by specific macros
written  in  IPP  that  apply  a  sequence  of  filters  and
transformations to each image of the stack in turn before
finally counting the resulting cells and transferring the data to
a spreadsheet for analysis. These subroutines were recently
described in detail [68,69].
The  topology  of  RGCs  was  analyzed  with  isodensity
maps. Cell densities were calculated and represented as a
filled  contour  plot  graph  following  previously  described
methods [68,69]. In brief, every captured frame was divided
into an equal number of 36 rectangular areas of interest (AOI)
for OHSt labeling and 25 AOI for Brn3a labeling. These AOI
were automatically counted, and data was exported and saved
to a spreadsheet computer program (Microsoft Office Excel
2003; Microsoft Corporation, Redmond, WA). Finally, the
data were represented as a filled contour plot using graphing
software (SigmaPlot 9.0 for Windows; Systat Software, Inc.,
Richmond,  CA)  that  constructs  pseudocolored  isodensity
maps in a scale of 45 different steps (each of 125) ranging
from 0 to 5,625 cells/mm2. This upper limit was chosen on the
basis of earlier studies that showed mean highest densities
around this value [69].
The RGCs expressing aberrant RT97 staining of their
soma were counted in a masked fashion in 5 experimental and
5 naïve retinas from group II, sacrificed 17 days after lasering.
This survival interval was chosen because it has been shown
in  rats  that  the  largest  number  of  RT97  immunopositive
(RT97+) RGCs occurs between two and three weeks after
injury,  either  by  axotomy  [74]  or  by  elevated  IOP  [26].
Digitized retinal whole-mount reconstructions were examined
frame by frame at high magnification, and every RT97+ RGC
was marked with a colored dot to identify either faint or strong
RT97 immunoreactivity with the aid of Photoshop® software.
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counted  the  number  of  dots  (RT97+  RGCs)  and  their
topological distribution within each analyzed retina [26,74].
The retinal distribution of RT97+ RGCs and OHSt+ RGCS
within  the  same  retina  was  examined  by  comparing  their
respective topological maps.
Statistical  analysis:  In  quantitative  morphological  studies,
data are presented as mean±standard deviation (SD) while in
quantitative electrophysiological studies, data are represented
as  mean±standard  error  of  the  mean  (SEM).  Statistical
analysis of the differences between groups of retinas or groups
of animals was conducted with non-parametric ANOVA tests
using Satistix® V1.0 for Windows® 95 (Analytical Software,
Tallahassee, FL) software; the Kruskal–Wallis test was used
to compare more than two groups, and the Mann–Whitney test
was used when comparing two groups only. Differences were
considered significant when p<0.05.
RESULTS
Laser-induced intraocular pressure values: There was some
variability among maximum IOP values in the lasered eyes
within individuals and within groups processed at different
survival intervals, but the results were generally consistent.
Individual IOP measurements in the groups sacrificed at 8, 17,
35, and 63 days after laser treatment are shown in detail in
individual histograms for each group (group I; Figure 1A,
group II; Figure 1B, group III; Figure 1C, and group IV;
Figure 1D). Overall, our data show a similar time course
elevation of the IOP for all groups of mice. The statistical
analysis showed that within animal groups, IOP values were
comparable in the lasered eyes at 24 h (Kruskal–Wallis test,
p=0.0891) and 48 h (Kruskal–Wallis test, p=0.9024) after
lasering. In general, an important increase of the IOP was
already evident and peaked at 24 h after lasering (Kruskal–
Wallis test, p<0.0001); this was maintained for four days and
returned gradually after the fifth day to the basal value, so that
by one week after lasering, the IOP values in animals of
different groups were comparable for both eyes (Kruskal–
Wallis test, p=0.8191; Figure 1).
Electroretinography responses:
ERGs in control albino mice—To study the effect of
IOP elevation on the ERG waves in albino mice, simultaneous
ERG recordings were performed on the right and left eyes of
each animal before surgery. Before surgery, no significant
differences were observed between the left and right eyes in
any of the animals in the STR, a-wave, and b-wave ERG
amplitudes or in the implicit times for the b-waves. Figure 2
shows a representative example of ERG traces recorded in
both  eyes  before  surgery  in  response  to  flash  stimuli  of
increasing intensity. The STRs were elicited by weak light
stimuli  (−5.4  to  −4.02  log  cd·s·m−2).  The  STR  amplitude
increased exponentially with the intensity of the light stimuli.
No ERG a-wave was observed for light intensities below
−2.80 log cd·s·m−2. The b-wave elicited by light intensities
beginning  at  −3.96  cd·s·m−2  also  increased  exponentially,
reaching its maximum for 2.03 cd·s·m−2. The photopic ERG
response  was  elicited  by  a  light   intensity  of  2.03  log 
−2  cd·s·m    after 5 min of light adaptation (Figure 2).
Electroretinography  in  experimental  albino  mice
after elevated intraocular pressure—ERG recordings were
performed simultaneously for right untreated and left lasered
eyes in albino Swiss mice at increasing survival intervals after
lasering. Recordings from representative mice in groups III
(sacrificed at 35 days) and IV (sacrificed at 63 days) are shown
in Figure 2 and Figure 3, respectively. In addition, data are
shown  as  percentages  (mean±SEM)  of  reduction  in  wave
amplitudes in operated eyes with respect to baseline values
obtained for the same eyes before surgery (Figure 4). These
figures illustrate that reductions in pSTR after lasering are
maintained over time. Moreover, the changes observed in the
a- and b-wave amplitudes of the scotopic and mixed ERG
were obvious at short intervals (7 days and 4 weeks) and were
maintained  for  long  periods  after  lasering  (8  weeks).  A
reduction in the b-wave amplitude of the photopic response
was also observed after eye lasering (see photopic response in
Figure 2).
Group  II:  Mice  from  this  group  (n=13)  showed  pSTR
reductions of approximately 87% and 83%, respectively, 1
and 7 days after lasering when compared to their baseline
(preoperative values; t-test, p<0.001). Scotopic and mixed
ERG recorded in these mice 1 and 7 days after lasering showed
reduced a-wave amplitudes of 68% and 67% and reduced b-
wave  amplitudes  of  72%  and  71%,  respectively  (t-test,
p<0.001; Figure 4A).
Group III: ERG traces from this group (n=18) were recorded
before laser treatment and 1, 7, 14, and 28 days after treatment.
When compared to their baseline (preoperative values), there
were  significant  (t-test,  p<0.001)  reductions  in  pSTR  of
approximately 94%, 83%, 85%, and 60%, respectively, when
analyzed  at  1,  8,  14,  and  28  days.  Similarly,  significant
reductions were seen in the a- and b-wave amplitudes over the
same period: a-waves were 72%, 69%, 58%, and 45% of their
baseline at 1, 8, 14, and 28 days, and b-waves were 72% 66%,
66%, and 55% of their baseline at 1, 8, 14, and 28 days,
respectively (t-test, p<0.001) (Figure 2, Figure 4B).
Group IV: ERG traces from a representative mouse in group
IV (n=13), recorded before laser treatment and 1, 7, 14, 28,
42, and 56 days after treatment, are shown in Figure 3. When
laser-treated  eyes  are  compared  to  contralateral  untreated
fellow eyes, mice in this group showed significant (t-test,
p<0.001) reductions in pSTR of approximately 81%, 90%,
72%, 56%, 77%, and 74%, respectively, at 1, 7, 14, 28, 42,
and 56 days. Similarly, there were significant reductions in
the a- and b-wave amplitudes: Compared with the values
recorded in their fellow eyes (t-test, p<0.001; Figure 4C) the
a-wave amplitudes of the treated eyes were observed at 64%,
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recorded   before    and  four  weeks 
after     laser     photocoagulation  in 
one       representative  animal.
Electroretinogram  recordings  in
response to flash stimuli of increasing
intensity for the untreated right eye (blue
traces) and for the lasered left eye (red
traces) from one animal in group III. The
intensity  of  the  flash  stimulus  is
indicated  to  the  left  of  each  of  the
recording  traces.  No  difference  was
observed between the electroretinogram
amplitudes  of  the  left  and  right  eyes
before laser treatment (0 days), while a
significant reduction in all components
is clearly visible in the treated eye at four
weeks post-treatment (4 weeks), both in
scotopic and photopic light conditions.
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days, respectively, while b-wave amplitudes were 54%, 64%,
60%,  47%,  49%,  and  59%,  respectively,  for  the  same
intervals.
Time  course  of  ocular  hypertension-induced  loss  of
retrograde-labeled retinal ganglion cells: To determine the
effects of elevated IOP on the retrograde axonal transport of
OHSt, groups of mice were analyzed at increasing survival
intervals  of  8,  17,  35,  and  63  days  after  lasering.  Some
variability  was  observed  among  animals  belonging  to  the
same  group,  in  that  individual  retinas  exhibited  variable
numbers of OHSt-labeled RGCs (Figure 5) and differed in
corresponding  areas  of  the  retina  without  labeled  RGCs
(Figures 6 and Figure 7). Most of the lasered retinas analyzed
at 8, 17, 35, and 63 days showed typical areas lacking RGCs
labeled with OHSt that had been applied to both SCi one week
before animal processing. The areas that lacked OHSt-labeled
RGCs were comparable in the four groups of retinas (Figure
6).
Experimental retinas from the different groups showed
mean total numbers of retrograde-labeled RGCs that were
significantly  less  than  in  their  untreated  fellow  retinas
(Kruskal–Wallis test, p<0.0001). For group I, the treated eyes
had approximately 28% of the OHSt-labeled RGCs in the
untreated eyes (Mann–Whitney test, p<0.0001); for group II,
Figure  3.  Electroretinogram  traces  from  a  laser-treated  eye  in  a
representative  adult  albino  Swiss  mouse.  Electroretinogram
recordings in response to flash stimuli of increasing intensity for the
from a representative animal in group IV registered before laser
treatment (0 h) and 24 h, 1 week, 4 weeks, 6 weeks and 8 weeks later.
We found a significant reduction in the scotopic threshold response,
a-wave, and b-wave amplitudes by 24 h after lasering, amounting to
approximately  81%,  64%,  and  54%  of  their  basal  values,
respectively. The changes observed in the electroretinogram never
fully recovered for survival times of up to 8 weeks after lasering,
indicating that these are permanent.
23%  (Mann–Whitney  test,  p=0.0001);  for  group  III,  26%
(Mann–Whitney  test,  p=0.0000);  and  for  group  IV,  22%
(Mann–Whitney test, p=0.0001) (Figure 5). The mean number
of OHSt-labeled RGCs in the left (experimental) retinas of the
groups sacrificed 8, 17, 35, and 63 days after lasering were
13,428±6,295 (n=12), 10,456±14,301 (n=13), 12,622±14,174
(n=21), and 10,451±13,949 (n=13), respectively, while the
right  (untreated)  retinas  presented  mean  total  numbers  of
47,223±2,936 (n=12), 46,321±4,492 (n=13), 49,101±3,489
(n=21) and 47,748±2,829 (n=13), respectively (Figure 5). The
mean  total  numbers  of  OHSt-labeled  RGCs  in  the
contralateral retinas from the four groups were comparable
(Kruskal–Wallis test, p=0.1391). Similarly, the mean total
numbers of OHSt-labeled RGCs in the lasered retinas from
the four groups were also comparable (Kruskal–Wallis test,
p=0.2991), indicating that in this experimental paradigm, the
lack of OHSt-labeled RGCs is present by 8 days after lasering
and does not progress beyond that point (Figure 5).
Retinal distribution of retrograde-labeled retinal ganglion
cells: Microscopic examination of the control fellow retinas
showed the typical distribution of RGCs throughout the retina
(Figure 7A–C), while the lasered retinas revealed large areas
devoid of OHSt-labeled RGCs (Figure 6A–L and Figure 7D–
L).  This  absence  was  seen  in  approximately  91%  of  the
experimental retinas, in the form of a wedge-shaped space
with an apical vertex toward the optic disc. Approximately
94%  of  the  retinas  showed  these  areas  lacking  RGCs
backlabeled with OHSt in the upper retina. The pattern of
OHSt-labeled  RGC  distribution  within  the  retina  was
examined in detail by constructing an isodensity map for each
retina (Figure 6 A–L). Representative examples that illustrate
typical areas lacking OHSt-labeled RGCs, as well as their
topological distribution, are shown in Figure 6 and Figure 7.
When analyzed 8 (Figure 6A–C), 17 (Figure 6D–F and Figure
7D–F), 35 (Figure 6G–I and Figure 7G–I), and 63 (Figure 6J–
L and Figure 7J–L) days after lasering, approximately 100%,
92%, 86%, and 92% of the retinas, respectively, showed areas
lacking  RGCs  labeled  with  OHSt.  These  contour  plot
isodensity maps revealed that in addition to the retinal sectors
that  lacked  backlabeled  RGCs,  there  was  also  a  diffuse
absence  of  OHSt-labeled  RGCs  even  within  retinal  areas
where some labeled RGCs appeared (Figure 6 and Figure 7).
Thus, the lack of OHSt-labeled RGCs within the OHT retinas
was both focal and diffuse.
Double labeling of retinal ganglion cells: Animals from all
groups were backlabeled with OHSt applied to both SCi one
week before sacrifice. In addition, in groups II (n=13), III
(n=12), and IV (n=13), DTMR was applied to the ocular stump
of the intraorbitally transected left optic nerve 5 days after
OHSt application and 2 days before sacrifice. OHSt would
identify  RGCs  that  retained  their  retrograde  axoplasmic
transport capacities, while DTMR would identify RGCs with
a competent axon at the level of the ON head. In general, there
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Figure  4.  Histograms  illustrating  evolving  changes  in  the
electroretinograms. Average values (mean±SEM) of the positive
scotopic threshold response (pSTR) and a- and b-waves are presented
as percentages of their basal values in three different experimental
groups  that  were  analyzed  at  increasing  survival  intervals  and
sacrificed at 17 (A), 35 (B), or 63 (D) days after lasering. At 24 h
after laser treatment, a large reduction can be seen in the amplitudes
of all the registered waves when compared to their basal levels. These
reductions are maintained over time and do not recover significantly
even for the animal group examined at 8 weeks after lasering (C),
suggesting  that  laser  treatment  induces  a  permanent  functional
impairment within the innermost, inner and outer retina.
OHSt-labeled RGCs and the areas lacking DTMR-labeled
RGCs (Figure 7A–L).
Immunocytofluorescence studies:
Brn3a immunostaining of the retina—To determine
whether the absence of backlabeled RGCs represented actual
RGC death or a functional impairment of axonal transport,
retinal whole-mounts of mice analyzed 8 (n=12) or 35 (n=9)
days  after  lasering  were  processed  for  Brn3a
immunohistochemistry to identify and count surviving RGCs.
These retinas had been labeled with OHSt applied to both SCi
one week before sacrifice. Control retinas showed a typical
distribution  of  OHSt-labeled  RGCs  throughout  the  retina
(Figure  8A),  and  the  retinal  distribution  of  Brn3a-labeled
RGCs  (Figure  8B)  paralleled that  of  OHSt-labeled  RGCs
(Figure 8 C,D), as recently described for rats [51]. The average
total numbers of Brn3a-labeled RGCs in the right control
retinas at 8 and 35 days were 49,375 (±2,822; n=12) and
50,577  (±2,036;  n=9),  respectively.  The  left  LP  retinas
Figure 5. Populations of retinal ganglion cells labeled with 10%
hydroxystilbamidine methanesulfonate at 8, 17, 35, and 63 days after
lasering. Histograms represent the mean (±SD) total numbers of
retinal ganglion cells (RGCs) labeled with 10% hydroxystilbamidine
methanesulfonate (OHSt) in the left eye (LE) and right eye (RE) for
groups I, II, III, and IV, analyzed 8, 17, 35 or 63 days, respectively,
after  laser  treatment  of  the  LE.  To  identify  RGCs  capable  of
retrograde  axonal  transport,  OHSt  was  applied  to  both  superior
colliculi 1 week before sacrifice. Retinas were imaged with adjacent,
nonoverlapping frames captured in a raster pattern. OHSt-labeled
RGCs were counted in each frame using image analysis software.
The average total numbers of OHSt-labeled RGCs in the LE were
approximately  one  fourth  of  the  total  numbers  of  OHSt-labeled
RGCs found in their untreated fellow retinas (RE) at all time points
studied. The mean total numbers of OHSt-labeled RGCs in the RE
for  all  four  groups  were  comparable  (*Kruskal–Wallis  test;
p=0.1391). Similarly, the mean total numbers of OHSt-labeled RGCs
in the lasered retinas (LE) for these groups were also comparable
(**Kruskal–Wallis test; p=0.2991). This suggests that the loss of
retrograde axonal transport does not change beyond 8 days.
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n=12)  and  10,219  (±8,887;  n=9)  Brn3a-labeled  RGCs,
respectively. Eight days after lasering, these numbers were
greater  than  those  obtained  for  the  OHSt-labeled  RGCs
(13,428±6,295; n=12) (Mann–Whitney test, p=0.0007; Figure
8E–F),  but  35  days  after  treatment  the  numbers  were
comparable  (10,522±9,426;  n=9;  Mann–Whitney  test,
p=0.9397;  Figure   8G–H).   The   progressive   diminution 
of    the    total   number   of     Brn3a-labeled    RGCs    in
treated   retinas  analyzed   8  and  35  days   after   lasering
Figure  6.  Isodensity  maps  of  retinal
ganglion  cells  labeled  with  10%
hydroxystilbamidine  methanesulfonate
in experimental retinas. The isodensity
maps  of  representative  experimental
retinas from groups I (A-C), II (D-F), III
(G-I),  and  IV  (J-L)  illustrate  regions
with  different  densities  of  retinal
ganglion  cells  labeled  with  10%
hydroxystilbamidine  methanesulfonate
(OHSt+  RGCs).  To  identify  RGCs
capable of retrograde axonal transport,
OHSt    was   applied    to   both 
superior colliculi  one  week  before
animal   processing.   Whole-mount
reconstructions were prepared with the
aid  of  a  motorized  stage  on  a
photomicroscope with a high-resolution
camera connected to an image analysis
system  (Image-Pro  Plus,  V5;  Media
Cybernetics,  Silver  Spring,  MD).
Retinal multi frame acquisitions were
photographed in a raster scan pattern in
which contiguous frames were captured
with no gap or overlap. Isodensity maps
were  generated  by  assigning  a  color
code to each of the 36 subdivisions of
each individual frame according to its
RGC  density  value  within  a  45-step
color scale range, from 0 (dark blue) to
5,625 RGCs/mm2 or higher (red). For all
retinas, the dorsal pole is orientated at
12 o’clock (scale bar=1 mm). Note that
there are many regions with focal loss—
that  is,  with  almost  no  backlabeled
RGCs  —  as  well  as  regions  with
sparsely  distributed  RGCs.  For
example,  the  retina  illustrated  in  E
shows a region containing backlabeled
RGCs restricted to a wedge between the
5 and 10 o’clock positions. The retina
illustrated in A also shows backlabeled
RGCs in higher numbers within a large
wedge between 5 and 10 o’clock, but
spared  RGCs  are  also  distributed
throughout  the  rest  of  the  retina  in
lighter  densities,  as  reflected  by  the
cooler than normal colors. In the four
groups,  approximately  91%  of  the
retinas show areas with severe absence
of RGCs. This absence is primarily (in
94% of the retinas) in the dorsal retina.
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RGCs (Table 1).
RT97 immunostaining of the retina—Dissected retinas
were  stained  with  RT97,  an  antibody  that  recognizes
phosphorylated  neurofilament  heavy  chain  (pNFH)  and
whose abnormal expression is an index of axonal injury [71,
81-88]. This antibody has been recently studied after optic
nerve axotomy, either by complete intraorbital optic nerve
transection or crush [74] or after ocular hypertension in adult
albino rats [26]. In the present study, fellow control retinas
showed typical RT97 immunostaining confined to the most
distal portion of the axons within the middle and central retina,
where they group into bundles and converge at the optic disk.
Rarely, an axon was stained to the retinal periphery, and RT97
staining was infrequently observed in the somas or dendrites
of RGCs (Figure 9A,B). In contrast, the pattern of RT97
expression in LP retinas processed at 8, 17, 35, and 63 days
after  lasering  showed  typical  signs  of  axotomy-induced
neuronal  degeneration  [26,74]  (Figure  9C,D).  In  general,
abnormal RT97 staining consisted mainly of abnormal pNFH
accumulations both in the intraretinal aspect of RCG axons
(shaped like rosary beads and small varicosities) and also
within the cell bodies and primary dendrites of some RGCs
(Figure 9D). RT97 labeling within the cell soma and primary
dendrites varied from a faint but clear staining to an intense
labeling (Figure 9C,D). Abnormal expression of RT97 was
confined  mainly  to  the  sectors  of  the  retina  that  lacked
backlabeled RGCs, while the areas showing OHSt-labeled
RGCs  presented  fewer  abnormalities  in  RT97
immunoreactivity, as recently described for other inherited
mouse models of ocular hypertension [53-57] and in a rat
model  of  ocular  hypertension  [26].  While  there  were  no
noticeable  changes  in  RT97  expression  eight  days  post-
treatment  when  the  retinas  were  examined  at  low
magnification, numerous RGC bodies and proximal dendrites
were positive for RT97 by 17 days after lasering (Figure
9C,D); still, it was rare to observe a OHSt+ RGC doubly
labeled with RT97, or vice versa (Figure 9 and Figure 10). At
35 and 63 days, the abovementioned changes in the RT97
expression pattern within axons had evolved further, and there
were fewer RT97+ RGCs.
In the five control retinas, the number of RT97+ RGCs in
each was 0, 0, 12, 15, and 13, respectively, with a mean (±SD)
of 8±7 (n=5). The 40 RT97+ RGCs found in control retinas
were all faintly stained. In contrast, in the 5 experimental
retinas, totals of 202, 415, 269, 165, and 291 RT97+ RGCs
were counted in each individual retina, with a mean (±SD) of
268±96 (n=5). Out of a total of 1,342 RT97+ RGCs found in
the experimental retinas, 27% were strongly labeled and 73%
were faintly stained. The population of RGCs in Swiss mouse
retinas has been recently shown to be of 49,493 RGCs [69];
thus, the population of RT97+ RGCs represented, in the best
case,  less  than  1%  of  the  total  population  of  RGCs.
Nevertheless, the number of RT97+ RGCs in the LP retinas
showed a great increase when compared to control retinas.
In the retinas in which manual counts were performed, a
comparison  of  the  topological  distribution  showed  that
RT97+ RGCs were mainly distributed in regions that lacked
OHSt-labeled RGCs. Two representative examples of this
spatial analysis are provided in Figure 10.
In the wedge-shaped sectors devoid of OHSt+ RGCs and
DTMR+ RGCs, normal-looking RT97 stained axonal bundles
were observed converging toward the optic disk throughout
the retina. By 63 days after LP, there was a diminution in the
density of RT97-labeled axonal bundles in the central and
peripheral  retina,  and  RT97-stained  somas  in  RGCs  were
infrequently observed.
DISCUSSION
The present study provides new information regarding the
effects of elevated IOP on adult albino Swiss mice and extends
our previous observations of the adult albino rat [26]. Lasering
of  the  limbal  and  perilimbal  veins  resulted  in  an  abrupt
increase of IOP, already measurable at 24 h, that persisted
until day 5, when IOP started to decrease gradually, reaching
preoperative  baseline  values  by  one  week  post-treatment.
Important diminutions in the numbers of backlabeled OHSt+
RGCs  were  already  evident  by  8  days  after  lasering  and
remained constant thereafter. Thus, the lack of OHSt+ RGCs
occurred soon after lasering, did not progress between 8 and
63 days and in general approximately 25% of the original
population  of  RGCs  maintained  their  retrograde  axonal
TABLE 1. TOTAL NUMBERS OF OHST+RGCS OR BRN3A+RGCS IN CONTROL AND INJURED RETINAS.
8 days after laser photocoagulation 35 days after laser photocoagulation
RGC cells RE (n=12) LE (n=12) RE (n=9) LE (n=9)
Brn3a+RGCs 49,375±2,822† 24,343±5,739*# 50,577±2,036† 10,219±8,887**#
OHSt+RGCs 47,223±2,936† 13,428±6,295* 46,649±2,693† 10,522±9,426**
Number (mean±SD) of RGCs immunodetected for Brn3a or labeled with OHSt applied to both superior colliculi one week
before  animal sacrifice, in contralateral (RE) or injured (LE) retinas of mice examined 8 or 35 days after laser photocoagulation
of the left eyes. *Mann–Whitney test, p=0.0007; **Mann–Whitney test, p=0.9397; # Mann–Whitney test, p=0.004; † Kruskal–
Wallis test, p=0.0796.
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2588Figure 7. Isodensity maps of retinal ganglion cells labeled with dextran tetramethylrhodamine and 10% hydroxystilbamidine methanesulfonate
in control and experimental retinas. Retinal whole-mounts of representative adult albino Swiss mice are shown at different survival intervals
after lasering the left eye and treating with dextran tetramethylrhodamine (DTMR) and 10% hydroxystilbamidine methanesulfonate (OHSt).
To identify retinal ganglion cells (RGCs) capable of retrograde axonal transport, OHSt was applied to both superior colliculi 1 week before
animal sacrifice, and to identify RGCs with a competent axon at the level of the optic nerve (ON) head, DTMR was applied to the ocular
stump of the intraorbitally divided ON 2 days before sacrifice. These retinal whole-mounts illustrate typical topological distributions of OHSt
+ RGCs and DTMR+ RGCs throughout these retinas. Note the close correspondence of the areas lacking backlabeled RGCs with both tracers
for each illustrated retina. For all retinas, the dorsal pole is orientated at the 12 o’clock position (scale bar=1 mm). A-C: Whole-mount of a
representative control right retina double-labeled with OHSt (A) applied 1 week before dissection and DTMR (B) applied 5 days later. An
isodensity map of OHSt-labeled RGCs was constructed by splitting each frame into 36 parts and estimating RGC densities (C). Intensely
labeled RGCs are distributed throughout the retina, but higher densities are present in a region along the naso-temporal axis of the superior
retina, resembling a visual streak [69]. D-F: Whole-mounts of a representative experimental left retina from Group II (17 days after lasering)
show the lack of OHSt-labeled RGCs (D) in a large sector that comprises the superior and small sectors of the inferior retina. Stained with
DTMR (E), the same retinal sector shows few to no DTMR-labeled RGCs. An OHSt-labeled RGC isodensity map (F) illustrates the areas
lacking backlabeled RGCs in a sector that spans almost from the 4 o’clock position to half past 8 o’clock. G-I: These whole-mounts of
representative experimental retinas from Group III (35 days after lasering) show important diminutions in the numbers of OHSt-labeled RGCs
(G) in all quadrants of the retina, except for the inferior-nasal. When stained with DTMR (H), the same retinal quadrants show few to no
DTMR-labeled RGCs. The OHSt-labeled RGC isodensity map (I) illustrates the areas that lack backlabeled RGCs. J-L: Whole-mounts of a
representative experimental retina from Group IV (63 days after lasering) show a lack of OHSt-labeled RGCs (J) mainly within the nasal
retina and the superior-temporal quadrant. Stained with DTMR (K), the same retinal quadrants showed few to no DTMR-labeled RGCs. The
OHSt-labeled RGC isodensity map (L) also illustrates the areas with focal loss of RGCs, as well as a small sector of the inferior temporal
quadrant that shows diffuse loss of backlabeled RGCs.
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geographical distribution of the backlabeled RGCs shows that
elevated IOP induces — as has been shown in the albino rat
[26] — both sectorial (in the form of wedge-shaped regions)
and diffuse loss of RGCs. Our immunofluorescence studies
also indicate that early after IOP elevation, retrograde axonal
transport is impaired in a subpopulation of RGCs that are
Brn3a+ and thus survive in the retina. RT97 immunostaining
further shows that in the sectors of the retina lacking OHSt+
RGCs, some surviving RGCs show typical signs of crush-
injury-like  induced  degeneration.  Our  electrophysiological
analysis  demonstrates  that  shortly  after  LP,  there  is  an
important reduction in the amplitude of the STR and the other
two main components of the ERG, the a- and b-waves; these
reductions  are  permanent  throughout  the  period  of  study,
indicating  that  elevation  of  IOP  in  albino  mice  results  in
damage not only to the RGC layer, but also to other retinal
layers.  All  together,  we  found  that  lasering  of  the  limbal
tissues  in  albino  mice  results  in  profound  alterations  of
retrograde  axoplasmic  transport  that  are  followed  by
degeneration of RGCs, as well as important alterations of the
innermost, inner nuclear, and outer nuclear layers of the retina.
Elevation of intraocular pressure: Elevation of IOP, the
primary risk factor for glaucoma, is also the most common
approach to induce experimental models in which to study
pathophysiology  involved  with  glaucomatous  optic
neuropathy. Injection of hypertonic saline into the episcleral
veins [89], cauterization of the episcleral veins [90], and laser
photocoagulation of the trabecular meshwork [30] are some
accepted approaches to induce ocular hypertension in animal
models  of  glaucomatous  damage.  Much  is  known  about
inherited mouse models of glaucoma, the DBA/2J line of
mice, and also about the experimentally induced models of
glaucoma in pigmented mice [32,33,59], but little is known
about the subject in albino mice.
The  extent  of  IOP  elevation  varies  with  different
experimental approaches and animal species [15,30]. Indeed,
different lasering methods result in different IOP elevation
profiles with variations in the time at which the peak IOP is
reached and maintained, as well as differences in how long
ocular  hypertension  persists  [15,30,89].  The  lasering
methodology employed in the present study resulted in a rapid
increase of IOP that was maintained for a short period of time.
While this may be seen as a disadvantage when compared to
a  more  chronic  model  of  IOP  elevation,  our  IOP  profile
produced a severe injury to the retina that resulted in several
features — loss of RGCs and degeneration of the nerve fiber
layer, for example — that are common in an inherited mouse
model  of  ocular  hypertension  [54-57]  commonly  used  to
investigate mechanisms of cell death in glaucomatous optic
neuropathy.  Similar  abrupt  elevations  of  IOP  have  been
observed  for  pigmented  mice,  in  which  the  trabecular
meshwork and the episcleral veins were photocoagulated with
a laser [60]. The pigmented mice studied by Grozdanic and
colleagues [12] showed persistent IOP increases for over 30
days, while in our study, the IOP elevation was restricted to
the  first  week.  Nevertheless,  our  results  are  somewhat
comparable, in that they also show important alterations of the
STR, a-waves, and b-waves of the ERG recordings, all of
which imply severe retinal damage (see below).
Absence  of  retrograde-labeled  retinal  ganglion  cells:
Evaluation of RGC survival was based on the use of specific
markers  and  retrograde-transported  tracers  that  allowed
specific identification of RGCs over flattened mouse retina
whole-mounts,  along  with  the  application  of  recently
developed techniques to automatically count labeled RGCs
and construct topological isodensity maps of their distribution
within the retina. Quantitative analysis of the number of RGCs
backlabeled  with  OHSt  applied  to  both  SCi  showed
substantial diminution of OHSt+ RGCs in lasered retinas when
compared with their contralateral fellow retinas. Within each
group examined at different survival intervals, there was some
variability in the intensity of retinal damage, as judged by the
size of areas lacking labeled RGCs and the total number of
RGCs  labeled  with  OHSt.  At  present,  we  have  no  clear
explanation for the variability of retinal damage in the present
work, but similar variations in the intensity of retinal damage
have been reported in experimental [30] and inherited [55,
56,59] models of ocular hypertension, including our recent
study that used similar lasering methodology in adult albino
rats  [26].  There  were  no  differences  among  the  groups
analyzed at different survival intervals; thus, it is conceivable
that whatever damage was induced in these retinas occurred
soon after injury.
The lack of retrograde-labeled cells in the experimental
retinas took two primary forms: a focal absence, in wedge-
shaped sectors with their vertex on the optic disc and their
periphery  toward  the  retinal  periphery;  and  another,  less
conspicuous reduction that was diffuse and affected retinal
areas containing some backlabeled RGCs. Focal loss occurred
in wedges of different sizes within the retinal quadrants but
more  often  in  the  dorsal  retina,  as  has  been  previously
observed in other ocular hypertension studies in rats [26,28,
30,89] and mice [54,55,59,64]. We ignore the exact reason for
the preferential location of retinal damage in the dorsal retina
but suppose it may be related to the basic structure of the optic
nerve. The spatial distribution of OHSt+ RGCs in the lasered
retinas  suggests  a  diffuse  lack  of  backlabeled  RGCs  in
addition to the focal loss of the cells. Indeed, the isodensity
maps constructed on the basis of the OHSt+ RGCs provided a
vivid demonstration of the presence of retinal areas with lower
than normal RGC densities (Figure 6,Figure 7, and Figure 8).
A  similar  pattern of  RGC loss  has  been  reported  in aged
DBA/2NNia mice [52] as well as in adult OHT rats [26].
Functional impairment of retrograde axonal transport:
The results for the experimental groups in which OHSt was
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2590Figure 8. Absence of backlabeled retinal
ganglion cells due to axonal transport
impairment and cell loss. A-H: These
representative  examples  show  whole-
mounts of a control retina (A-D) labeled
with  10%  hydroxystilbamidine
methanesulfonate  (OHSt)  (A)  and  its
isodensity map (C), as well as the same
retina immunolabeled with Brn3a (B) to
identify  surviving  RGCs  and  the
corresponding isodensity map (D). To
identify  RGCs  capable  of  retrograde
axonal transport, OHSt was applied to
both  superior  colliculi  1  week  before
sacrifice. To identify surviving RGCs,
retinas  were  processed  for  Brn3a
immunohistochemistry.  Note  the
presence  of  intensely  stained  RGCs
distributed throughout the entire control
retina, with a typical high-density region
along  a  naso-temporal  streak  in  the
superior retina, which is clearly shown
in the isodensity maps of OHSt-labeled
RGCs  (C)  and  Brn3a-labeled  RGCs
(D). E-H: Representative examples of
experimental retinas at 8 (E, F) and 35
(G, H) days after lasering, showing the
isodensity maps of OHSt-labeled RGCs
(E, G) and Brn3a-labeled RGCs (F, H).
Both experimental retinas show fewer
OHSt- and Brn3a-labeled RGCs than in
the  control  retinas.  Moreover,  the
population of Brn3a-labeled RGCs was
greater than that of OHSt-labeled RGCs
at  8  but  not  at  35  days,  indicating
compromised  retrograde  axonal
transport  within  the  first  week  after
lasering and demonstrating that the lack
of retrograde labeling in the retina is due
not only to RGC degeneration but also
to  an  impairment  of  the  axoplasmic
flow. The diminution in the numbers of
Brn3a+RGCs  observed  between  the
control retina and retinas analyzed 8 and
35 days after lasering also documents
the loss of RGCs. Isodensity maps were
generated by assigning a color code to
each  of  the  subdivisions  of  each
individual frame according to its RGC
density  value  within  a  45-step  color
scale range, from 0 (dark blue) to 5,625
RGCs/mm2  or  higher  (red).  For  all
retinas, the dorsal pole is orientated at
12 o’clock (scale bar=1 mm).
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2591used as a retrograde tracer to identify RGCs demonstrated
large areas of the retina that lacked labeled RGCs. While the
absence of backlabeled RGCs may reflect degeneration and
death  of  RGCs,  it  might  also  be  related  to  a  functional
impairment of axoplasmic flow, as has been previously shown
for  other  retinal  injuries  in  adult  rats,  such  as  transient
ischemia [43] or ocular hypertension [26]. In these studies it
was  shown  that  a  proportion  of  the  RGC  population  that
survives  transient  ischemia  of  the  retina  or  ocular
hypertension  exhibits  impairment  of  retrograde  axonal
transport [26,43]. To investigate whether the lack of OHSt-
labeled RGCs was a reflection of axonal transport impairment,
OHSt was applied to both SCi 1 wk before animal processing,
and  the  retinas  were  processed  for  Brn3a
immunohistofluorescence  to  identify  and  count  surviving
RGCs. There was a clear mismatch between the number of
OHSt+ RGCs and the number of Brn3a+ RGCs, indicating that
within the first days after lasering, retrograde axonal transport
of  OHSt  from  the  SCi  back  to  the  RGC  cell  body  is
compromised.  The  number  of  surviving,  functionally
competent  RGCs  is  much  larger  as  judged  by  Brn3a
expression, further demonstrating that not all surviving RGCs
retain  normal  physiologic  properties  [26,43].  These
experiments indicate that the lack of retrograde labeling in the
retina, at the early time point of 8 days after lasering, is due
not only to an actual degeneration and loss of RGCs but also
to an impairment of the axoplasmic transport.
The absence of OHSt+ RGCs in the wedge-shaped sectors
was paralleled by the lack of retrograde labeling with DTMR,
suggesting that the scarcity of labeled RGCs is due also to a
lack of passive diffusion along the RGC axon (Figure 7). It is
possible that early after lasering, within 8 days of treatment,
there  is  an  actual  impairment  of  active  retrograde  axonal
transport of OHSt along the axon, while by 17 or more days
after lasering, the lack of RGCs backlabeled with OHSt or
DTMR responds to impairment of active retrograde axonal
transport and of passive diffusion from the optic nerve head
toward the cell body. This is consistent both with a mechanical
obstruction altering passive diffusion and retrograde transport
of DTMR and also with retrograde cell loss of unlabeled
RGCs. Indeed, the observation that the number of Brn3a+
RGCs diminishes progressively from the control samples to
retinas examined at 8 days and then retinas examined at 35
days provides evidence for the loss and death of RGCs. Thus,
it seems that OHT induces not only a scarcity of labeled RGCs
but also the death of RGCs.
Axotomy-like  injury  post-ocular  hypertension:  The
topologic  distribution  of  RGCs  in  the  form  of  triangular
sectors suggests a lesion inflicted at a point where optic axons
are topographically grouped together; this must occur at the
level of the optic nerve head, where retinotopic arrangement
is highest [91,92]. These wedge-shaped patterns of retinal
damage are reminiscent of those observed in other types of
inherited or acquired retinal degeneration, in which blood
vessels ligate bundles of axons, thus producing an intense
constriction that leads to axonal transport interruption, loss of
retrograde tracing, and loss of RGCs [71,83-86]. The latter
situation affects bundles of axons close to the optic disc, with
effects that radiate out toward the periphery, but no anomalies
are  seen  within  unconstricted  bundles  of  axons.  The
geographical distribution of areas without backlabeled RGCs
in our present study sharply contrasts with the characteristic
patchy cell loss observed after transient ischemia of the retina
induced by selective ligature of the ophthalmic vessels [43,
72,73].
It was interesting to find apparently normal neurofilament
staining  in  sectors  with  labeled  RGCs,  but  not  in  sectors
lacking labeled RGCs (Figure 9C,D). In agreement with our
double-labeling studies, which showed that a large number of
surviving Brn3a+ RGCs had lost their capacity for retrograde
axonal transport of OHSt, some RT97+ RGCs were found
within the areas that lacked labeled RGCs, as were bundles of
RT97+  retinal  axons  (Figure  9C,D  and  Figure  10).  This
suggests  that  retrograde  degeneration  and  death  of  OHT-
lesioned RGCs and their axons takes longer, as previously
suggested [26,54,56]. The degenerative events in the ganglion
cell layer following optic nerve injury vary depending on the
type of injury and are somewhat slower when the injury is due
to  axonal  compression  than  when  it  is  due  to  axonal
transection [74].
There  was  no  indication  of  further  diminution  in  the
numbers of OHSt+ RGCs between 8 and 63 days after lasering.
By 63 days, the retinas showed total numbers of OHSt+ RGCs
that were not significantly different from those observed in
the similar groups of animals processed at 8, 17, and 35 days
after  lasering,  implying  that  perhaps  the  numbers  of
backlabeled RGCs do not decrease further with increasing
survival intervals. Progressive loss of RGCs was observed
when  these  neurons  were  identified  with  Brn3a
immunofluorescence, which agrees with previous studies of
RGC loss induced by an axotomy-like insult, such as ON
transection [93], ON crush [74,94], or axon bundle ligation
[71,83-86].
Functional  impairment  of  the  retina
(electroretinography): Our previous studies on OHT-induced
retinal  degeneration  in  adult  rats  [26],  together  with  the
present  studies,  indicate  that  shortly  after  IOP  elevation,
severe pathology develops in the retina, affecting the RGC
population. However, little is known about changes in retinal
function in an OHT model induced by LP of episcleral and
limbal veins in adult albino Swiss mice; thus, ERG were
recorded in this study to examine functionally the progression
of retinal damage in living animals induced by OHT over time
in this experimental paradigm.
It is likely that IOP elevation results in permanent damage
to the outer retinal layers, because in our experiments, both
the a-wave and the b-wave amplitudes diminish soon after
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2592lasering and do not recover with time. Indeed, our results are
consistent with other studies in rat OHT eyes showing severe
alteration of the a- and b- waves shortly after OHT only when
the  peak  of  IOP  is  elevated  [13,14,17,95,96].  Whether
diminution in the amplitudes of the a- and b-waves reflects a
functional impairment that precedes actual degeneration of
the  outer  retinal  layers  remains  to  be  studied  further,  but
parallel studies conducted in our laboratory [97] suggest that
Figure  9.  Ocular  hypertension  induces  aberrant  expression  of
phosphorylated  neurofilament  heavy  chain.  Fluorescence
photomicrographs show representative middle regions of right eye
(control; A, B) and left eye (lasered; C, D) mouse retinas, with 10%
hydroxystilbamidine  methanesulfonate  (OHSt)  applied  to  the
superior  colliculi  for  1  week,  that  were  processed  for  RT97
immunofluorescence  17  days  after  laser  photocoagulation.
Micrographs were taken under ultraviolet and fluorescein filters to
examine OHSt or RT97 immunofluorescence, respectively. A, B: In
the  control  (right-eye)  retina,  OHSt-labeled  RGCs  show  typical
distribution  (A)  and  RT97  immunofluorescence  is  restricted  to
axonal  bundles  (B).  C,  D:  In  the  lasered  (left-eye)  retina,  the
distribution of retinal ganglion cells (RGCs) retrograde-labeled with
OHSt is restricted to the lower part of the picture (C), which under
the fluorescein filter (D) shows a lack of RT97 staining within OHSt
+  RGCs.  Abnormal  phosphorylated  neurofilament  heavy  chain
expression, which depicts several intensely RT97-stained RGCs and
RT97 beaded axons, is concentrated in the region that lacks OHSt
backlabeled RGCs. Scale bars for A-D=50 µm.
the degeneration of the outer retinal layers is a protracted event
following IOP elevation. In those studies, the morphology and
Figure 10. Different geographical distribution of RT97-labeled and
OHSt-labeled  retinal  ganglion  cells  in  retinas  with  ocular
hypertension.  These  examples  of  representative  left  retinas  in
experimental animals 17 days after lasering the left eye show retinal
ganglion  cells  (RGCs)  labeled  with  10%  hydroxystilbamidine
methanesulfonate  (OHSt)  and  RT97,  illustrating  the  near
confinement of abnormal expression of RT97 to sectors of the retina
that lack OHSt backlabeled RGCs; meanwhile, sectors containing
OHSt+ RGCs present fewer RGCs with abnormal RT97 staining. To
identify RGCs capable of retrograde axonal transport, OHSt was
applied to both superior colliculi 1 week before sacrifice. Retinal
whole-mounts were immunostained with RT97 antibodies to identify
RT97+  RGCs.  OHSt+  RGC  isodensity  maps  were  generated  by
assigning  a  color  code  to  each  of  the  36  subdivisions  of  each
individual frame according to its density value within a 45-step color
scale, ranging from 0 (dark blue) to 5,625 RGCs/mm2 or higher (red).
RT97+ RGCs are represented as dots over the outline of the retinal
whole-mount. A, B: A whole-mount of a representative experimental
left retina doubly labeled with OHSt (A) and RT97 (B) illustrates the
typical topological distribution of 12,821 OHSt+ RGCs and 415
RT97+ RGCs throughout the retina in these experiments. Note the
lack  of  correspondence  between  areas  containing  OHSt-labeled
RGCs (A), which are restricted to a large wedge located between the
5 and 10 o’clock positions, and the RT97+ RGCs (B), which are
distributed mainly in the opposite area of the retina. The dorsal pole
of  the  retina  is  orientated  at  12  o’clock.  C,  D:  Another  whole-
mounted representative experimental left retina doubly labeled with
OHSt (C) and RT97 (D) illustrates the topological distribution of
10,911 OHSt+ RGCs and 269 RT97+ RGCs throughout the retina in
these experiments. Note the lack of correspondence between areas
containing OHSt-labeled RGCs (C) which are restricted to a large
wedge between 4:30 and 8:30 o’clock, and the RT97+ RGCs (D)
found mainly in the opposite area of the retina. The dorsal pole of
the retina is orientated at 12 o’clock (scale bar=1 mm).
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2593general appearance of the outer retinal layers, as observed
with several antibodies, do not appear altered shortly after
lasering (two weeks post-treatment), but they become very
distorted by 4 months after lasering. Our present results are
also consistent both with other rat OHT eye studies that show
cellular disorganization and thickness reduction of all retinal
layers [12] and a severe thinning of the retinal structures
[14] and also with reports in human advanced glaucoma that
indicate altered scotopic ERG parameters [8] and thinning of
the outer and inner nuclear layers with loss of photoreceptors
[6].
Our  results  on  the  recorded  a-waves  and  b-waves
illustrate damage to the outer and middle retinal layers, but
they  provide  no  information  about  the  innermost  retina.
Recording STR, the lowest detectable response in scotopic
conditions, appears to be a fine and sensitive functional test
to  detect  damage  to  the  innermost  layer  of  the  retina,
specifically involving the RGC population [13,98]. In both
pigmented [13,37] and albino [38] rats, the STR diminishes
significantly  shortly  after  optic  nerve  transection,  a
diminution  that  correlates  with  the  pattern  of  axotomy-
induced RGC loss and persists for long periods of time without
recovery, indicating that the integrity of the RGC population
is  needed  to  evoke  a  full  STR  in  these  rodents.  Our
measurement of ERG responses using a series of flashes with
varying light intensity allowed us to evaluate the functional
changes longitudinally; the results showed that the STR was
severely  affected  shortly  after  the  rise  in  IOP,  and  this
alteration  was  maintained  throughout  the  longest  survival
interval  examined,  8  weeks,  thus  providing  additional
functional evidence of the loss of RGCs in this model. This is
consistent with previous OHT studies in adult albino rats
[26], as well as with our present anatomic data indicating
degeneration of the RGC population. Moreover, a significant
reduction in STR has been associated with chronic [14,17,
60,99,100] and acute [95,101] OHT in adult rats, mice [96],
and monkey OHT models and human glaucoma patients [8,
98].
Thus, taken together our present data shows that elevation
of IOP in albino mice results in important diminutions of the
STR, a-wave, and b-wave amplitudes, which are generated by
the innermost, outer and inner nuclear layers of the retina,
respectively. A similar effect has been observed in rat and
monkey models of glaucoma [14,98]. To our knowledge, we
report for the first time significant decreases in STR, a-wave,
and b-wave ERG scotopic responses in adult albino Swiss
mice  with  elevated  IOP.  Correspondence  in  physiologic
measurements in this mouse OHT model indicates the value
of  noninvasive  ERG  measurements  to  document  retinal
pathophysiology in rodent glaucoma models.
Concluding remarks: Our data indicate that OHT in adult
albino Swiss mice induces several severe degenerative events
in the retina. The first event observed in our experiments is
the loss of the capacity for active retrograde axonal transport
from target territories in the brain back to cell soma in the
retina. This is seen within a week of retinal lasering. Shortly
after,  axonal  transport  appears  blocked  for  bundles  of
neighboring  axons,  in  such  a  way  that  even  a  passively
diffusing retrograde tracer does not reach the somas of the
surviving RGCs in the retina; this appears between 8 and 17
days after lasering and is maintained for the period of study.
At the early time point (8 days), however, there are still larger
numbers  of  RGCs  distributed  throughout  the  retina,  as
identified  by  the  expression  of  the  RGC-specific  marker
Brn3a. Simultaneously, the nerve fiber layer of the retina
shows signs of retrograde degeneration of axons and RGC
bodies that are compatible with an axotomy-like injury, and
the chronology of the degenerative events speaks in favor of
a crush-like injury to bundles of axons in the ON head. Up to
63 days post-treatment, the retinas exhibit a small proportion
(approximately 22%) of the original RGC population that
maintains their capacity both for active retrograde transport
of OHSt from their target territories in the brain back to the
retina and for passive retrograde diffusion of DTMR from the
ON head toward the cell soma in the retina. These events are
paralleled by an important functional impairment that consists
of reductions in the amplitudes of the a- and b-waves and the
STR wave to approximately half of their basal levels. These
reductions, which are observed as early as 24 h after laser
treatment, are maintained for as long as 8 weeks, suggesting
permanent damage to the innermost, inner nuclear and outer
nuclear layers of the retina.
The mechanism by which the outer, inner and innermost
retinal layers are compromised in the present model is not
fully understood, but it may result from different types of
insults. It has been largely known that increased IOP may
mimic the effect of an axotomy-like injury to RGC axons
somewhere near the optic nerve head [26,102-104], where ON
axons  are  highly  arranged  retinotopically  [91,92].
Additionally,  the  inner  retinal  blood  supply  may  also  be
compromised  by  ON  head  compression;  thus,  a  vascular
compromise or mechanical compression of retinal vessels
cannot  be  disregarded  completely  [105-107].  Finally,
astrocytes  have  also  been  implicated  in  the  structural
remodeling  that  occurs  in  the  optic  nerve  head  of
glautomatous  eyes,  thus  glial  activation  may  also  be  an
important contributor to glaucomatous optic neuropathy [56,
108].
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